Alteration of cholinergic pressor and antinociceptive responses in rats pretreated with the cholinergic toxin AF64A.
1. In the present study, the pressor and antinociceptive effects of physostigmine and oxotremorine were investigated in rats injected with AF64A intracerebroventricularly. 2. Physostigmine (50-100 micrograms/kg, i.v.)-induced pressor responses were significantly lower in AF64A-injected rats compared with saline-injected animals, whereas oxotremorine (20-80 micrograms/kg, i.v.)-induced responses were found to be similar to those seen in the saline group. 3. The physostigmine (100 micrograms/kg, s.c.)-induced antinociceptive effect was totally abolished by AF64A treatment, but that of oxotremorine (30 micrograms/kg, s.c.) remained unchanged at the tail-flick test. 4. The results of this study present functional evidence for AF64A-produced substantial loss of cholinergic neurons involved in the regulation of blood pressure and nociception but not in postsynaptic muscarinic receptors.
Tellioğlu
T
T
Department of Pharmacology, Marmara University School of Medicine, Istanbul, Turkey.
Erin
N
N
Akin
S B
SB
Berkman
K
K
Oktay
S
S
D000698:Analgesia; D000818:Animals; D001362:Avoidance Learning / Q000187:drug effects*; D001388:Aziridines / Q000494:pharmacology*; D002794:Choline / Q000031:analogs & derivatives* / Q000494:pharmacology; D002800:Cholinesterase Inhibitors / Q000494:pharmacology; D005260:Female; D008297:Male; D018782:Maze Learning / Q000187:drug effects*; D018721:Muscarinic Agonists / Q000494:pharmacology; D009466:Neuromuscular Blocking Agents / Q000494:pharmacology*; D010095:Oxotremorine / Q000494:pharmacology; D010147:Pain Measurement; D010830:Physostigmine / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley
D001388:Aziridines; D002800:Cholinesterase Inhibitors; D018721:Muscarinic Agonists; D009466:Neuromuscular Blocking Agents; D010095:Oxotremorine; D010830:Physostigmine; C044894:ethylcholine aziridinium; D002794:Choline